Professor Sir Tom Blundell

FRS, FmedSci

Professor Blundell is Sir William Dunn Professor of Biochemistry and Chair of Biological Sciences, University of Cambridge. He is a Member of EMBO and Academia Europaea, a Fellow of the Royal Society and of the Academy of Medical Sciences. He has Honorary Fellowships at Linacre and Brasenose Colleges, Oxford and at Birkbeck College, London, a Professorial Fellowship at Sidney Sussex, Cambridge and Honorary Doctorates from fourteen universities. He is President of the Biosciences Federation, and until 2005 was Chairman of the Royal Commission on Environmental Pollution. He previously held positions in Oxford and Sussex Universities, and the Bernal Chair of Crystallography in Birkbeck College, University of London.

He has consulted with a number of large pharmaceutical companies, including Pfizer, Parke Davis, SKB, Zeneca and Glaxo. He was previously on the Board of Celltech and Chairman of their Science and Technology Committee. He was Chief Executive Officer of AFRC and BBSRC and co-founded Astex Therapeutics Ltd, a private drug discovery company.